Tag:
Vivopharma
Latest Headlines
Latest Headlines
ViroPharma, Halozyme tackle hereditary angioedema treatment
ViroPharma ( $VPHM ) and Halozyme ( $HALO ) said they have generated positive early data in a Phase II trial of a drug delivery platform used to treat hereditary angioedema, a life-threatening immune
